0 false false false false false false false false false false true false false false false false false No description of principal activity 2024-06-01 Sage Accounts Production Advanced 2024 - FRS102_2024 xbrli:pure xbrli:shares iso4217:GBP 03948770 2024-06-01 2025-05-31 03948770 2025-05-31 03948770 2024-05-31 03948770 2023-06-01 2024-05-31 03948770 2024-05-31 03948770 2023-05-31 03948770 bus:Director1 2024-06-01 2025-05-31 03948770 core:ShareCapital 2025-05-31 03948770 core:ShareCapital 2024-05-31 03948770 bus:SmallEntities 2024-06-01 2025-05-31 03948770 bus:AuditExemptWithAccountantsReport 2024-06-01 2025-05-31 03948770 bus:SmallCompaniesRegimeForAccounts 2024-06-01 2025-05-31 03948770 bus:PrivateLimitedCompanyLtd 2024-06-01 2025-05-31 03948770 bus:FullAccounts 2024-06-01 2025-05-31
COMPANY REGISTRATION NUMBER: 03948770
Eden Pharmacy Limited
Filleted Unaudited Financial Statements
31 May 2025
Eden Pharmacy Limited
Balance Sheet
31 May 2025
2025
2024
Note
£
£
£
Current assets
Debtors
4
1,000
1,000
-------
-------
Net current assets
1,000
1,000
-------
-------
Total assets less current liabilities
1,000
1,000
-------
-------
Capital and reserves
Called up share capital
1,000
1,000
-------
-------
Shareholders funds
1,000
1,000
-------
-------
These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies' regime and in accordance with Section 1A of FRS 102 'The Financial Reporting Standard applicable in the UK and Republic of Ireland'.
In accordance with section 444 of the Companies Act 2006, the statement of income and retained earnings has not been delivered.
For the year ending 31 May 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
Directors' responsibilities:
- The members have not required the company to obtain an audit of its financial statements for the year in question in accordance with section 476 ;
- The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of financial statements .
These financial statements were approved by the board of directors and authorised for issue on 29 May 2026 , and are signed on behalf of the board by:
Mr H A Patel
Director
Company registration number: 03948770
Eden Pharmacy Limited
Notes to the Financial Statements
Year ended 31 May 2025
1. General information
The company is a private company limited by shares, registered in England and Wales. The address of the registered office is Devonshire House, 582 Honeypot Lane, Stanmore, HA7 1JS.
2. Statement of compliance
These financial statements have been prepared in compliance with Section 1A of FRS 102, 'The Financial Reporting Standard applicable in the UK and the Republic of Ireland'.
3. Accounting policies
Basis of preparation
The financial statements have been prepared on the historical cost basis. The financial statements are prepared in sterling, which is the functional currency of the entity.
Financial instruments
Financial instruments are classified and accounted for, according to the substance of the contractual arrangement, as either financial assets, financial liabilities or equity instruments. An equity instrument is any contract that evidences a residual interest in the assets of the company after deducting all of its liabilities.
Debtors
Basic financial assets, including trade and other debtors, are initially recognised at transaction price, unless the arrangement constitutes a financing transaction, where the transaction is measured at the present value of the future receipts discounted at a market rate of interest. Such assets are subsequently carried at amortised cost using the effective interest method, less any impairment.
Cash and cash equivalents
Cash and cash equivalents are represented by cash in hand, deposits held at call with financial institutions, and other short-term highly liquid investments that mature in no more than three months from the date of acquisition and that are readily convertible to known amounts of cash with insignificant risk of change in value.
Creditors
Basic financial liabilities, including trade and other creditors, loans from third parties and loans from related parties, are initially recognised at transaction price, unless the arrangement constitutes a financing transaction, where the debt instrument is measured at the present value of the future payments discounted at a market rate of interest. Such instruments are subsequently carried at amortised cost using the effective interest method, less any impairment.
4. Debtors
2025
2024
£
£
Amounts owed by group undertakings and undertakings in which the company has a participating interest
1,000
1,000
-------
-------
5. Controlling party
Eden Pharmacy Limited is a wholly owned subsidiary of Jaypri Limited, a company incorporated in England and Wales. The ultimate controlling party is Globereen Healthcare Limited, a company incorporated in England and Wales.